ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Diagnosis and rheumatoid arthritis (RA)"

  • Abstract Number: 1482 • 2018 ACR/ARHP Annual Meeting

    Is 14.3.3η a Predictor of Development of Rheumatoid Arthritis in Patients with Early Undifferentiated Arthritis?

    Karen Marie Carlsen1, Nina Schmidt2, Anne Duer3, Kim Hørslev-Petersen4, Cecilie Heegaard Brahe5, Merete Lund Hetland2, Norma K Biln6, Michelle L Zaharik7, Bo Jannik Ejbjerg8, Lene Bak9, Michael Sejer Hansen10, Julia Sidenius Johansen11, Hanne Merete Lindegaard12, Jakob M. Møller13 and Mikkel Østergaard14, 1Center for Rheumatology and Spine Diseases,, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet Hillerød, Denmark, Hillerød, Denmark, 2Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Denmark, Glostrup, Denmark, 3Department of Radiology, Rigshospitalet Glostrup, Denmark, Glostrup, Denmark, 4King Christian the Xth Hospital for Rheumatic Diseases, Denmark, Graasten, Denmark, 5Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Rigshospitalet, Centre for Head and Orthopaedics, Rigshospitalet, Glostrup, Denmark, 6Augurex Life Sciences Corp, Vancouver, BC, Canada, 7Augurex Life Sciences Corp, Vancouver, DC, Canada, 8Rheumatology, Department of Rheumatology, Køge Hospital, Denmark, Køge, Denmark, 9Department of Radiology, Odense University Hospital, Denmark, Odense, Denmark, 10Reuma-Klinik Roskilde, Denmark, Roskilde, Denmark, 11Dept. of Oncology, Department of Oncology, Copenhagen University Hospital, Herlev and Gentofte, Herlev, Denmark, 12Dept. of Rheumatology, Department of Rheumatology, Odense University Hospital, Denmark, Odense, Denmark, 13Department of Radiology, Copenhagen University Hospital Herlev, Copenhagen, Denmark, 14Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Denmark, Copenhagen, Denmark

    Background/Purpose: Optimal management of rheumatoid arthritis (RA) requires early diagnosis and therefore sensitive methods for early identification of RA to prevent joint damage and disability.…
  • Abstract Number: 2362 • 2017 ACR/ARHP Annual Meeting

    Novel Biomarkers for the Prediction of Subclinical Coronary Artery Atherosclerosis in Patients with Rheumatoid Arthritis

    Joan Bathon1, Jenny Van Eyk2, Nick Knowlton3, Ivan Ferraz-Amaro4, Jon T. Giles5, C. Michael Stein6, Mary Chester M. Wasko7 and Michael Centola8, 1Division of Rheumatology, Columbia University, College of Physicians & Surgeons, New York, NY, 2Advanced Clinical BioSystems Research Institute , Cedars-Sinai Medical Center, Los Angeles, CA, 3Department of Arthritis and Clinical Rheumatology, Oklahoma Medical Research Foundation, Oklahoma, OK, 4Rheumatology, Hospital Universitario de Canarias, La Laguna, Tenerife, Spain, 5Division of Rheumatology, Columbia University College of Physicians & Surgeons, New York, NY, 6Medicine, Vanderbilt University Medical Center, Nashville, TN, 7Lupus Center, Pittsburgh, PA, 8Arthritis and Immunology, Oklahoma Medical Research Foundation, Oklahoma, OK

    Background/Purpose: Cardiovascular (CV) disease risk prediction models, that were originally developed for use in the general population, have been found to have suboptimal performance in…
  • Abstract Number: 2965 • 2017 ACR/ARHP Annual Meeting

    Non-Invasive Imaging Methods for Evaluating the Cardiovascular Involvement in Patients with Rheumatoid Arthritis before and after 18 Months of Treatment with Anti-TNF Drugs

    Fabiola Atzeni1, Luigi Gianturco2, Laura Boccassini3, Piercarlo Sarzi-Puttini3 and Maurizio Turiel4, 1Rheumatology Unit, ASST Fatebenefratelli - Sacco, L. Sacco University Hospital, Milano, Italy, 2Beato Matteo” Hospital, GSD Foundation, Vigevano, Italy, Vigevano, Italy, 3Rheumatology Unit, ASST Fatebenefratelli - Sacco, L. Sacco University Hospital, Milan, Italy, 4IRCCS, Galeazzi Orthopedic Institute, Dept. Biomedical Sciences for Health, University of Milan, Milan, Italy

    Background/Purpose: The aim of this study was to evaluate left ventricular myocardial function with two- dimensional speckle tracking echocardiography (STE), in addition to conventional Doppler…
  • Abstract Number: 500 • 2016 ACR/ARHP Annual Meeting

    Can Thiol/Disulphide Is a Novel Marker in Rheumatoid Arthritis?

    Sema Haliloglu1, cemile bicer2, Murat Alisik3, Bilge Ekinci4, Mehmet Emin Budak5, Omur volkan6, Hulya Uzkeser7 and Ayse Carlioglu8, 1Physical Medicine and Rehabilitation, Maltepe Occupational Diseases Hospital, Istanbul, Turkey, 2Biochemistry, Yildirim Beyazit University Medical Faculty, Ankara, Turkey, 3Biochemistry, Ataturk Training and Research Hospital, Ankara, Turkey, 4Physical Medicine and Rehabilitation, Erzurum Region Training and Research Hospital, Erzurum, Turkey, 5Endocrinology, Erzurum Region Training and Research Hospital, erzurum, Turkey, 6Rheumatology, Erzurum Region Training and Research Hospital, Erzurum, Turkey, 7Physical Medicine and Rehabilitation, Ataturk University,Medical Faculty, Erzurum, Turkey, 8Endocrinology, Erzurum Region Training and Research Hospital, Erzurum, Turkey

    Background/Purpose:  Rheumatoid arthritis is a chronic, systemic, autoimmune disease about 5% -%1 of world population affected. Highly reactive oxygen free radicals are believed to be…
  • Abstract Number: 1037 • 2016 ACR/ARHP Annual Meeting

    Evaluation of 14-3-3η As a Tool for Diagnosis of Early RA in a European Cohort

    Monika Hansson1, Linda Mathsson-Alm2, Anthony Marotta3 and Sascha Swiniarski4, 1Rheumatology Unit, Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden, 2Thermo Fisher Scientific, Uppsala, Sweden, 3Augurex Life Sciences Corp., Vancouver, BC, Canada, 4ImmunoDiagnostics Division Thermo Fisher Scientific, Phadia GmbH, Freiburg, Germany

    Background/Purpose: Early diagnosis of rheumatoid arthritis (RA) coupled with an effective treatment strategy is a key imperative in the effective management of disease. Anti-citrullinated peptide…
  • Abstract Number: 1508 • 2016 ACR/ARHP Annual Meeting

    Prevalence and Clinical Characteristics of Rheumatoid Arthritis in Sickle Cell Patients: A Cross-Sectional Analysis

    David J. Ozeri1, Joshy Pathiparampil2, Randolph Sanchez2 and Isabel M. McFarlane3, 1Rheumatology, SUNY Downstate Medical Center, brooklyn, NY, 2Internal Medicine, SUNY Downstate Medical Center, Brooklyn, NY, 3Rheumatology, SUNY Downstate Medical Center, Brooklyn, NY

    Title: Prevalence and Clinical Characteristics of Rheumatoid Arthritis in Sickle Cell Patients Background/Purpose: Rheumatoid arthritis (RA) has been rarely reported in association with sickle cell…
  • Abstract Number: 493 • 2015 ACR/ARHP Annual Meeting

    Diagnostic Delay in Early Arthritis: Ten Years-Experience of a Single Center

    Francesca Benaglio, Silvia Balduzzi, Serena Bugatti, Garifallia Sakellariou, Carlomaurizio Montecucco and Roberto Caporali, Division of Rheumatology, University of Pavia, IRCCS S. Matteo Foundation, Pavia, Italy, Pavia, Italy

    Background/Purpose: In the last 10 years a big effort has been made to reduce the diagnostic delay in patients with early arthritis, in order to…
  • Abstract Number: 1869 • 2013 ACR/ARHP Annual Meeting

    Serum Cytokine/Chemokine Profiles Are Useful For Evaluating Pathological Conditions Of Rheumatoid Arthritis and Diagnosing Anti-CCP Antibody-Negative Patients

    Hitoshi Uga1, Takahiro Okazawa1, Yoshiaki Miyamoto1, Takehiro Hasegawa1, Jun Saegusa2, Goh Tsuji3, Sho Sendo4, Akio Morinobu5, Shunichi Kumagai6,7 and Hirokazu Kurata1, 1Sysmex Corporation, Kobe, Japan, 2Department of Evidence-based Laboratory Medicine, Kobe University Graduate School of Medicine, Kobe, Japan, 3Center for Rheumatic Diseases, Shinko Hospital, Kobe, Japan, 4Center of rheumatic diseases, Shinko Hospital, Kobe, Japan, 5Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Kobe, Japan, 6Center of rheumatic diseases, Shinko hospital, Kobe, Japan, 7Department of Evidence-Based Laboratory Medicine, Kobe University Graduate School of Medicine, Kobe, Japan

    Background/Purpose: The diagnosis of anti-CCP antibody (ACPA) negative rheumatoid arthritis (RA) are known to be difficult and delayed as compared with ACPA-positive RA. This study…
  • Abstract Number: 1786 • 2013 ACR/ARHP Annual Meeting

    91% Of Early RA Patients Are Positive For Serum 14-3-3η Or Its Auto-Antibodies

    Walter P. Maksymowych1, Dirkjan van Schaardenburg2, Désirée van der Heijde3, Robert Landewé4, Gilles Boire5, Maarten Boers6, Vivian P. Bykerk7, Edward C. Keystone8, Katherine A. Siminovitch9, Mairead Murphy10 and Anthony Marotta11, 1Medicine, University of Alberta, Edmonton, AB, Canada, 2Jan van Breemen Research Institute | Reade, Jan van Breemen Research Institute | Reade, Amsterdam, Netherlands, 3Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 4Int Med/Rheumatology, Academic Medical Center, Amsterdam, Netherlands, 5Rheumatology Division, Centre Hospitalier Universitaire de Sherbrooke, Université de Sherbrooke, Sherbrooke, QC, Canada, 6Epidemiology & Biostatistics, VU University Medical Center, Amsterdam, Netherlands, 7Rheumatology, Hospital for Special Surgery, Weill Cornell Medical College, New York, NY, 8Department of Medicine, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, 9Mount Sinai Hospital, Toronto, ON, Canada, 10Augurex Life Sciences Corp., North Vancouver, BC, Canada, 11Augurex Life Sciences Corp, North Vancouver, BC, Canada

    Background/Purpose: Current serological markers such as RF and ACPA are useful for early diagnosis and perhaps for screening people at risk, but there remains a…
  • Abstract Number: 876 • 2013 ACR/ARHP Annual Meeting

    Prediction Of TNF Inhibitor Response In Rheumatoid Arthritis Patients Using Single Cell Network Profiling Of Intracellular Immune Signaling

    Jason Ptacek1, Rachael Hawtin2, Brent Louie1, Erik Evensen1, James Cordeiro1, Barbara Mittleman1, Michelle Atallah1, Alessandra Cesano2, Clifton O. Bingham III3, Stacey Cofield4, Jeffrey R. Curtis5, Maria I. Danila4, Richard A. Furie6, MC Genovese7, Marc C. Levesque8, Larry W. Moreland8, Peter A. Nigrovic9, James R. O'Dell10, William H. Robinson11, Nancy A. Shadick9, E. William St Clair12, Christopher C. Striebich13, Geoffrey M Thiele14, Peter K. Gregersen6 and S. Louis Bridges Jr.4, 1Nodality, Inc., South San Francisco, CA, 2Nodality Inc., South San Francisco, CA, 3Rheumatology, Johns Hopkins University, Baltimore, MD, 4University of Alabama at Birmingham, Birmingham, AL, 5Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 6The Feinstein Institute for Medical Research and North Shore-Long Island Jewish Health System, Lake Success, NY, 7Stanford University, Palo Alto, CA, 8University of Pittsburgh, Pittsburgh, PA, 9Brigham and Women's Hospital/Harvard University, Cambridge, MA, 10Veteran Affairs Nebraska Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, NE, 11VA Palo Alto Health Care System and Stanford University, Palo Alto, CA, 12Medicine, Duke Unversity Medical Center, Durham, NC, 13University of Colorado Denver, Aurora, CO, 14Omaha VA and the University of Nebraska Medical Center, Omaha, NE

    Background/Purpose:   Biomarkers predictive of drug efficacy are lacking in rheumatoid arthritis (RA) and would be useful in clinical practice and clinical trials.  Single cell…
  • Abstract Number: 2264 • 2013 ACR/ARHP Annual Meeting

    An Assay Panel Combining Anticitrullinated Peptide Autoantibodies and Rheumatoid Factor Isotypes Has High Yield In The Diagnosis Of Rheumatoid Arthritis

    Nirupa J. Patel1, Ignacio Garcia-Valladares2, Derren Barken3, Luis R. Espinoza4, Heena Sheth5 and Thierry Dervieux6, 1Rheumatology, LSU Health Sciences Ctr, New Orleans, LA, 2Rheumatology, Guadalajara, Guadalajara, Mexico, 3Exagen Diagnostics, Vista, CA, 4Medicine-Section of Rheum, LSU Medical Center, New Orleans, LA, 5Medicine, University of Pittsburgh, Pittsburgh, PA, 6Research and Development, Exagen Diagnostics, Vista, CA

    Background/Purpose: We sought to establish the diagnostic performances of rheumatoid factor isotypes (IgM and IgA) and anti-citrullinated peptide antibodies (ACPAs: anti-mutated citrullinated vimentin [anti-MCV] and…
  • Abstract Number: 2132 • 2012 ACR/ARHP Annual Meeting

    Disease Activity and Anti-CCP Status, but Not Sociodemographic Factors or Patient Comorbidities, Affect Time to Diagnosis in Early Rheumatoid Arthritis

    Cheryl Barnabe1, Juan Xiong2, Gilles Boire3, Carol A. Hitchon4, Boulos Haraoui5, Janet E. Pope6, J. Carter Thorne7, Edward Keystone8, Diane Tin9, Vivian P. Bykerk10 and Canadian ArThritis CoHort11, 1Medicine, Community Health Sciences, University of Calgary, Calgary, AB, Canada, 2University of Toronto, Toronto, Canada, 3Rheumatology Division, Centre Hospitalier Universitaire de Sherbrooke, Université de Sherbrooke, Sherbrooke, QC, Canada, 4University of Manitoba, Winnipeg, MB, Canada, 5Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Montreal, QC, Canada, 6Medicine/Rheumatology, St. Joseph Health Care London, University of Western Ontario, London, ON, Canada, 7Southlake Regional Health Centre, Newmarket, ON, Canada, 8University of Toronto, Toronto, ON, Canada, 9The Arthritis Program, Southlake Regional Health Centre, Newmarket, ON, Canada, 10Rheumatology, Hospital for Special Surgery, New York, NY, 11Toronto

    Background/Purpose: Delays in patient presentation to primary care providers,  subsequent referral for rheumatology assessment, and recognition of rheumatoid arthritis (RA) by the rheumatologist increase time…
  • Abstract Number: 2096 • 2012 ACR/ARHP Annual Meeting

    A Prediction Rule for the Progression to Rheumatoid Arthritis Applied in a Mexican Mestizo Cohort with Undifferentiated Arthritis

    Ana Arana Guajardo, Lorena Pérez Barbosa, David Vega Morales, Janett Riega Torres, Roberto Negrete López, Jacqueline Rodríguez Amado, Jorge Esquivel Valerio, Cassandra Skinner Taylor, Diana Flores Alvarado, Dionicio Galarza Delgado, Miguel Villarreal Alarcon and Mario Garza Elizondo, Rheumatology, Hospital Universitario, UANL, Monterrey, Mexico

    Background/Purpose: A high proportion of patients who present with recent-onset arthritis have undifferentiated arthritis (UA), as these patients do not fulfill the classification criteria for…
  • Abstract Number: 441 • 2012 ACR/ARHP Annual Meeting

    Performance of Anti-Cyclic Citrullinated Peptide Assays Differs in Healthy Subjects At Elevated Risk for Future Rheumatoid Arthritis and Subjects with Established Disease

    M. Kristen Demoruelle1, Mark Parish2, Lezlie A. Derber3, Michael H. Weisman4, William R. Gilliland5, Jess Edison6, James R. O'Dell7, Ted R. Mikuls8, Richard M. Keating9, Peter K. Gregersen10, Jane H. Buckner11, Jill M. Norris12, V. Michael Holers13 and Kevin D. Deane1, 1Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO, 2Rheumatology, University of Colorado Anschutz Medical Campus, Aurora, CO, 3University of Colorado School of Medicine, Division of Rheumatology, Aurora, CO, 4Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, 5Walter Reed National Military Medical Center, Bethesda, MD, 6Department of Rheumatology, Walter Reed National Military Medical Center, Bethesda, MD, 7Dept of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, 8Internal Medicine, University of Nebraska Medical Center, Omaha, NE, 9Rheumatology Section, The University of Chicago, Chicago, IL, 10Genomics and Human Genetics, North Shore University Hospital Research Center, Manhasset, NY, 11Benaroya Research Institute at Virginia Mason, Seattle, WA, 12Epidemiology, Colorado School of Public Health, Aurora, CO, 13Rheumatology Division, University of Colorado School of Medicine, Aurora, CO

    Background/Purpose: The 2010 ACR/EULAR RA criteria include autoantibodies to cyclic citrullinated peptides (CCP) that are highly specific for RA in the setting of inflammatory arthritis…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology